Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...

Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...

Wilson OKs plan for 1-million-square-foot warehouse The plan, known as Easton Commerce Park, would occupy the former 106.2-acre Pfizer Pigments site on Wood Avenue.